# L-GLUTAMINE
> **ANDA219750** · Abbreviated New Drug Application (Generic) · Sponsor: RENOVA PHARMS · Approved 2026-05-14
## Drug
- **FDA Application Number:** ANDA219750
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** L-GLUTAMINE
- **Generic name:** L-GLUTAMINE
- **Active ingredients:** L-GLUTAMINE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** RENOVA PHARMS
- **Manufacturer:** Renova Pharmaceuticals LLC
- **First approval:** 2026-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219750)
---
*MORVS · CC0 1.0*